Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasdaq
Marketing
Cybin alters state to become Helus Pharma for Nasdaq trip
Cybin is shedding its old identity, evolving into Helus Pharma as part of changes that will see its shares move to a different stock exchange.
Nick Paul Taylor
Dec 19, 2025 10:30am
Viatris launches brand campaign on Nasdaq tower in Times Square
Nov 16, 2023 10:53am
Cash-strapped VBL sells manufacturing plant for $7.1M
Feb 16, 2023 10:05am
Cognos strikes SPAC merger to fund implantable drug delivery R&D
Jan 10, 2023 10:35am
ObsEva will slash 70% of its staff, saving $7.6M annually
Sep 13, 2022 10:29am
Otsuka drops Akebia in oral anemia drug pact
May 16, 2022 9:23am
